MPB Personnel

Beverly A. Teicher, Ph.D.
Chief, Molecular Pharmacology Branch

Dr. Beverly A. Teicher PhD is currently Chief of the Molecular Pharmacology Branch at NCI, a position that she assumed in early 2011. A major focus of the Molecular Pharmacology Branch is target and drug discovery in the disease areas of sarcoma and small cell lung cancer. More…

Nathan P. Coussens, Ph.D.

Nathan P. Coussens, Ph.D., is the director of the Molecular Pharmacology Laboratories at the Frederick National Laboratory for Cancer Research, where he leads three teams focused on the preclinical development of cancer therapeutics. More…

Thomas S. Dexheimer, Ph.D.

Thomas S. Dexheimer, Ph.D. is the Lab Head of the NCI60 Screening Laboratory and the Target Validation and Screening Laboratory, a position that he assumed in September 2020. Dr. Dexheimer completed a Ph.D. in Pharmaceutical Sciences at the University of Arizona and postdoctoral training at the National Cancer Institute, NIH. More…

Mark W. Kunkel, Ph.D.

Mark W. Kunkel, Ph.D., joined the Molecular Pharmacology Branch in 2023 after spending a decade in the Drug Synthesis and Chemistry Branch and a decade before that in the Information Technology Branch. His graduate work at The University of Texas in Houston focused on cell signaling using classical biochemical methods. More…

Annamaria Rapisarda, Ph.D.

Dr. Annamaria Rapisarda obtained her Ph. D in Molecular Biological Science and her Specialization degree in Clinical Pathology from University of Genoa, Italy. She spent four years as a post-doctoral fellow and seven years as a scientist in the Tumor Hypoxia Laboratory, at the National Cancer Institute, under the supervision of Dr. Giovanni Melillo. More…